Kallikrein 8 antibody (AA 51-150) (Biotin)
Quick Overview for Kallikrein 8 antibody (AA 51-150) (Biotin) (ABIN759118)
Target
See all Kallikrein 8 (KLK8) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 51-150
-
Cross-Reactivity
- Human, Mouse, Rat
-
Predicted Reactivity
- Dog,Cow,Pig,Horse,Guinea Pig
-
Purification
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from mouse KLK8
-
Isotype
- IgG
-
-
-
-
Application Notes
-
IHC-P 1:200-400
IHC-F 1:100-500 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20°C for 12 months.
-
Expiry Date
- 12 months
-
-
- Kallikrein 8 (KLK8)
-
Alternative Name
- KLK8
-
Background
-
Synonyms: BSP1, Nrpn, Prss19, Kallikrein-8, mK8, Neuropsin, NP, Serine protease 19, Klk8
Background: Serine protease which is capable of degrading a number of proteins such as casein, fibrinogen, kininogen, fibronectin and collagen type IV. Also cleaves L1CAM in response to increased neural activity. Induces neurite outgrowth and fasciculation of cultured hippocampal neurons. Plays a role in the formation and maturation of orphan and small synaptic boutons in the Schaffer-collateral pathway, regulates Schaffer-collateral long-term potentiation in the hippocampus and is required for memory acquisition and synaptic plasticity. Involved in skin desquamation and keratinocyte proliferation. Plays a role in the secondary phase of pathogenesis following spinal cord injury.
-
Gene ID
- 259277
-
UniProt
- Q61955
-
Pathways
- Complement System
Target
-